Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2627]

ASCO 2012: Afatinib delays progression of advanced lung adenocarcinomas, particularly in genetic subset of tumours

ASCO 2012: Afatinib delays progression of advanced lung adenocarcinomas, particularly in genetic subset of tumours

ASCO 2012: Study shows routine molecular testing of non-small cell lung cancers is feasible in community settings

ASCO 2012: Study shows routine molecular testing of non-small cell lung cancers is feasible in community settings

ATM and MET kinases are antagonists of p53-dependent apoptosis

ATM and MET kinases are antagonists of p53-dependent apoptosis

ASCO 2012: Lower-income patients less likely to participate in clinical trials

ASCO 2012: Lower-income patients less likely to participate in clinical trials

Robot-assisted surgery for cancer – greater precision for the surgeon and clear benefits for the patient, but can the costs be justified?

Robot-assisted surgery for cancer – greater precision for the surgeon and clear benefits for the patient, but can...

Policy of including smokers in donor pool improves survival rates for patients on lung transplant waiting lists and should be continued

Policy of including smokers in donor pool improves survival rates for patients on lung transplant waiting lists...

Shelved sleep disorder drug neutralises 'undruggable' cancer cells

Shelved sleep disorder drug neutralises 'undruggable' cancer cells

Chemotherapy and radiation given together could help elderly patients with lung cancer live longer

Chemotherapy and radiation given together could help elderly patients with lung cancer live longer

Low-dose CT screening may benefit individuals at increased risk for lung cancer

Low-dose CT screening may benefit individuals at increased risk for lung cancer

New drug combination in lung cancer investigated

New drug combination in lung cancer investigated

More from ecancer